ORGO logo

Organogenesis Holdings (ORGO) EBITDA

Annual EBITDA

$15.76 M
-$12.19 M-43.60%

December 31, 2024

Summary

Performance

1-Year Change

-43.6%

3-Year Change

-81.88%

5-Year Change

+179.87%

15-Year Change

+1828.4%

ORGO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.3%
ORGO annual EBITDA is higher than 81.3% of companies in Healthcare sector

High & Low

All-time High

$87.00 M
ORGO annual EBITDA is currently -81.88% below its historical high of $87.00 million

3-Year Low

$15.76 M
ORGO annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ORGO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ORGO next annual earnings announcement has not yet been scheduled

OtherORGOprofitabilitymetrics:

Annual Revenue

$482.04 M
ORGO annual revenue is $482.04 million

Annual Net Income

$861.00 K
ORGO annual net profit is $861.00 thousand

Annual EBIT

-$1.26 M
ORGO annual earnings before interest & taxes is -$1.26 million

Annual EPS

-$0.01
ORGO annual earnings per share is -$0.01

Quarterly EBITDA

$14.64 M
+$3.94 M+36.86%

December 31, 2024

Summary

Performance

3-Month Change

+36.86%

1-Year Change

+36.86%

3-Year Change

-40.4%

5-Year Change

-8.47%

ORGO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.14%
ORGO quarterly EBITDA is higher than 84.14% of companies in Healthcare sector

High & Low

All-time High

$27.34 M
ORGO quarterly EBITDA is currently -46.46% below its historical high of $27.34 million

3-Year Low

-$9.72 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOprofitabilitymetrics:

Quarterly Revenue

$126.66 M
ORGO quarterly revenue is $126.66 million

Quarterly Net Income

$7.67 M
ORGO quarterly net profit is $7.67 million

Quarterly EBIT

$10.19 M
ORGO quarterly earnings before interest & taxes is $10.19 million

Quarterly EPS

$0.04
ORGO quarterly earnings per share is $0.04

TTM EBITDA

$15.76 M
+$11.72 M+290.17%

December 31, 2024

Summary

Performance

3-Month Change

+290.17%

1-Year Change

+290.17%

3-Year Change

-81.88%

5-Year Change

-75.98%

ORGO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.31%
ORGO TTM EBITDA is higher than 80.31% of companies in Healthcare sector

High & Low

All-time High

$93.49 M
ORGO TTM EBITDA is currently -83.14% below its historical high of $93.49 million

3-Year Low

$4.04 M
ORGO TTM EBITDA is currently +290.17% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOprofitabilitymetrics:

TTM Revenue

$482.04 M
ORGO TTM revenue is $482.04 million

TTM Net Income

$861.00 K
ORGO TTM net profit is $861.00 thousand

TTM EBIT

-$1.26 M
ORGO TTM earnings before interest & taxes is -$1.26 million

TTM EPS

-$0.02
ORGO TTM earnings per share is -$0.02

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$15.76 M
ORGO annual EBITDA is $15.76 million

Annual Net Income

$861.00 K
ORGO annual net profit is $861.00 thousand

Annual Interest Expense

$1.54 M
ORGO annual interest expense is $1.54 million

Annual Income Tax

-$3.67 M
ORGO annual income tax is -$3.67 million

Annual D&A

$17.03 M
ORGO annual depreciation & amortization is $17.03 million

ORGO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-43.6%+36.9%+290.2%
3 y3 years-81.9%-40.4%-81.9%
5 y5 years+179.9%-8.5%-76.0%

ORGO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.9%at low-40.4%+250.6%-81.9%+290.2%
5 y5-year-81.9%+179.9%-46.5%+221.5%-83.1%+177.5%
alltimeall time-81.9%+133.6%-46.5%+180.3%-83.1%+133.6%

Organogenesis Holdings EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$15.76 M(-43.6%)
$14.64 M(+36.9%)
$15.76 M(+290.2%)
Sep 2024
-
$10.70 M(-210.1%)
$4.04 M(-22.2%)
Jun 2024
-
-$9.72 M(-6850.0%)
$5.20 M(-81.5%)
Mar 2024
-
$144.00 K(-95.1%)
$28.15 M(+0.7%)
Dec 2023
$27.95 M(-15.4%)
$2.92 M(-75.4%)
$27.95 M(-23.4%)
Sep 2023
-
$11.85 M(-10.4%)
$36.49 M(+25.4%)
Jun 2023
-
$13.23 M(<-9900.0%)
$29.09 M(-4.7%)
Mar 2023
-
-$54.00 K(-100.5%)
$30.53 M(-7.5%)
Dec 2022
$33.02 M(-62.0%)
$11.46 M(+156.9%)
$33.02 M(-28.4%)
Sep 2022
-
$4.46 M(-69.6%)
$46.13 M(-24.1%)
Jun 2022
-
$14.66 M(+501.7%)
$60.76 M(-17.3%)
Mar 2022
-
$2.44 M(-90.1%)
$73.44 M(-15.6%)
Dec 2021
$87.00 M(+133.7%)
$24.57 M(+28.7%)
$87.00 M(+0.7%)
Sep 2021
-
$19.09 M(-30.2%)
$86.41 M(-7.6%)
Jun 2021
-
$27.34 M(+71.0%)
$93.49 M(+42.5%)
Mar 2021
-
$15.99 M(-33.3%)
$65.63 M(+74.6%)
Dec 2020
$37.23 M
$23.98 M(-8.4%)
$37.58 M(+129.9%)
Sep 2020
-
$26.17 M(-5133.3%)
$16.34 M(-203.6%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$520.00 K(-95.7%)
-$15.77 M(-22.4%)
Mar 2020
-
-$12.05 M(-539.7%)
-$20.34 M(+3.0%)
Dec 2019
-$19.74 M(-58.0%)
$2.74 M(-146.1%)
-$19.74 M(-28.1%)
Sep 2019
-
-$5.95 M(+17.0%)
-$27.45 M(-8.0%)
Jun 2019
-
-$5.08 M(-55.6%)
-$29.84 M(-25.7%)
Mar 2019
-
-$11.45 M(+130.1%)
-$40.17 M(-14.5%)
Dec 2018
-$46.98 M(+5051.3%)
-$4.98 M(-40.3%)
-$46.96 M(+3.8%)
Sep 2018
-
-$8.33 M(-45.9%)
-$45.23 M(+13.8%)
Jun 2018
-
-$15.41 M(-15.5%)
-$39.75 M(+61.8%)
Mar 2018
-
-$18.24 M(+461.9%)
-$24.56 M(+275.6%)
Dec 2017
-$912.00 K(-48.0%)
-$3.25 M(+13.8%)
-$6.54 M(-47.0%)
Sep 2017
-
-$2.85 M(+1186.3%)
-$12.34 M(+29.9%)
Jun 2017
-
-$221.80 K(+1.5%)
-$9.50 M(+2.4%)
Mar 2017
-
-$218.60 K(-97.6%)
-$9.28 M(+2.2%)
Dec 2016
-$1.75 M
-$9.04 M(>+9900.0%)
-$9.07 M(>+9900.0%)
Sep 2016
-
-$14.50 K(+2800.0%)
-$30.50 K(+90.6%)
Jun 2016
-
-$500.00(-96.8%)
-$16.00 K(+3.2%)
Mar 2016
-
-$15.50 K
-$15.50 K

FAQ

  • What is Organogenesis Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Organogenesis Holdings?
  • What is Organogenesis Holdings annual EBITDA year-on-year change?
  • What is Organogenesis Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Organogenesis Holdings?
  • What is Organogenesis Holdings quarterly EBITDA year-on-year change?
  • What is Organogenesis Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Organogenesis Holdings?
  • What is Organogenesis Holdings TTM EBITDA year-on-year change?

What is Organogenesis Holdings annual EBITDA?

The current annual EBITDA of ORGO is $15.76 M

What is the all time high annual EBITDA for Organogenesis Holdings?

Organogenesis Holdings all-time high annual EBITDA is $87.00 M

What is Organogenesis Holdings annual EBITDA year-on-year change?

Over the past year, ORGO annual EBITDA has changed by -$12.19 M (-43.60%)

What is Organogenesis Holdings quarterly EBITDA?

The current quarterly EBITDA of ORGO is $14.64 M

What is the all time high quarterly EBITDA for Organogenesis Holdings?

Organogenesis Holdings all-time high quarterly EBITDA is $27.34 M

What is Organogenesis Holdings quarterly EBITDA year-on-year change?

Over the past year, ORGO quarterly EBITDA has changed by +$3.94 M (+36.86%)

What is Organogenesis Holdings TTM EBITDA?

The current TTM EBITDA of ORGO is $15.76 M

What is the all time high TTM EBITDA for Organogenesis Holdings?

Organogenesis Holdings all-time high TTM EBITDA is $93.49 M

What is Organogenesis Holdings TTM EBITDA year-on-year change?

Over the past year, ORGO TTM EBITDA has changed by +$11.72 M (+290.17%)